Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers

British Medical Journal

Volumn 315, Issue 7109, 1997, Pages 646-649

  Bjørge, Tone ^a   Dillner, Joakim ^b   Anttila, Tarja ^c   Engeland, Anders ^a   Hakulinen, Timo ^d   Jellum, Egil ^e   Lehtinen, Matti ^c   Luostarinen, Tapio ^f   Paavonen, Jorma ^g   Pukkala, Ecro ^g   Sapp, Martin ^g   Schiller, John ^g   Youngman, Linda ^g   Thoresen, Steinar ^a  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d KAROLINSKA INSTITUTE   (Sweden)

^e Kreftforeningen   (Norway)

^f FINNISH CANCER REGISTRY   (Finland)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ANUS CANCER; ARTICLE; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FINLAND; FOLLOW UP; GENITAL TRACT CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; PENIS CANCER; PRIORITY JOURNAL; SERODIAGNOSIS; SEROEPIDEMIOLOGY; STRAIN DIFFERENCE; VAGINA CANCER; VIRUS INFECTION; VULVA CANCER; WART VIRUS;

EID: 9844238159     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.315.7109.646     Document Type: Article

References (36)

1. International Agency for Research on Cancer. Human papillomaviruses, Lyons: IARC, 1995. (IARC. monographs on the evaluation of carcinogenic risks to humans, vol 64.)
2. International Agency for Research on Cancer. Human papillomaviruses, Lyons: IARC, 1995. (IARC. monographs on the evaluation of carcinogenic risks to humans, vol 64.)
3. Cannistra SA, Niloff JM. Cancer of the uterine cervix. N Engl J Med 1996;334:1030-8.
4. Bosch FX, Marios MM, Munõz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillormavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
5. Zur Hausen H, de Villiers EM. Human papillomavinises. Annu Rev Microbiol 1994;48:427-47.
6. Schiffman MH, Bauer HM, Hoover RN, Glass AG., Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
7. Bjørge T, Hennig EM Skate GB, Søreide O, Thoresen SØ. Second primary cancers in patients with carcinoma in situ of the uterine cervix. The Norwegian experience 1970-1992. Int J Cancer 1995;62:29-33.
8. Melbve M, Sprøgel P. Aetiological parallel between anal cancer and cervical cancer. Lancet 1991;338:657-9.
9. Dillner J. Serology of human papillomavirus. Cancer J 1995;8:264-9.
10. Dillner J, Kalling I, Brihmer C, Sikström B, Schiller JT, Sapp M, et al. Seropositivities to human papillomavirus types 16, 18 and 33 capsids and to Chlamydia trachomatis are markers ol sexual behaviour. J Infect Dis 1996;173:1394-8.
11. Cheng G, Icenogle JP, Kirnbaner R, Hubbert NI., St Louis ME, Han C, et al. Divergent human papillomavirns type 16 variants are serologically cross-reactive. J Infect Dis 1995;172:1584-7.
12. Lehtinen M, Dillner J, Kneki P, Loustarinen T, Aromaa A, Kirnbauer R, et al. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical cancer: nested case-control study. BMJ 1996;312:537-9.
13. Jellum K, Andersen A, Lund-Larsen P, Theodorsen L, ØrjæterH. Experiences of the Janus Serum Bank in Norway. Environ health Perspect 1995;103 (suppl. 3):85-8.
14. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365-9.
15. Heino P, Eklund C, Fredriksson-Shanazarian V, Goldman S, Schiller JT, Dillner J. Association of serum immunologlobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma. J Natl Cancer Inst 1995;87:137-40.
16. Anderson-Ellström A, Dillner J, Hagmar B, Schiller J, Forssman L. No serological evidence for non-sexual spread of HPV16. Lancet 1994;344:1435.
17. Andersson-Ellström A, Dillner J, Hagmar B, Schiller J, Sapp M, Forssman I., et al. Comparison of development of serum antibodies to HPV 16 and HPV 33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sex Trans Dis 1996;23:234-8.
18. Dilner J, Wiklund F. Lenner P, Eklund C, Freidriksson-Shaazarian V, Schiller JT, et al. Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer. Int J Cancer 1995;60:377-82.
19. Kirnbauer R, Hubbert NI., Wheeler CM, Becker TM, Lowy DR, Schiller JT. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16 J Natl Cancer Inst 1994;86:494-9.
20. Chira KL, Wiklund F, Lenner P, Ingström T,Hallmans G, Sapp M, et al. A prospective cohort study on the risk in develop cervial intraepithelial neoplasm among healthy subjects with serum antibodies to HPV, in comparison with presence of HPV DNA in Papanicolaou smears. Int J Cancer 1996;68:54-9
21. Wang SP, Grayston JT. Immunologic relationship between genital TRIC. lymphogranoloma veneteum, and related organism in a new microtiter indirect immunofluorescence test. Am J Ophthalmol 1970;70:367-74.
22. Mehta CR, Patel NR. Exact logistic regression: theory and examples. Stat Med 1995;14:2143-60.
23. Cytel Software Corporation. LogNact-Turbo version 1.1. Cambridege, MA: Cytel Software Corporation. 1993.
24. Brinton I.A, Nasca PC, Mallin K, Baptiste MS, Wilbanks GD. Richart RM. Case-control study of cancer of the vulva. Obstet Gynecol 1990;75:859-66.
25. Ansink AC, Krul MR, De Weger RA, Kleyne JA, Pijpers H, Van Tinteren H, et al. Human papillomavirus, lichen sclerosiis. and squamous cell carcinoma of the vulvar detection and prognostic significanceGnecol Oncol 1994;52:180-4.
26. Hørding U, Junge J, Daugaard S, Lundvall F, Poulsen H, Bock JE. Vulvar squamous cell carcinoma and papillomaviruses: indications for two different etiologies. Gynecol Oncol 1994;52:241-6.
27. Milde-Langosch K, Albrecht K, Jorant S, Schlechte H, Gjessing M, Löning T. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int J Cancer 1995;63:639-45.
28. Trimble CL, Hildesheim A, Brinton LA, Shah KV, Kurman RJ. Heterogeneous etiology of squmaous carcinoma of the vulva. obstet Gynecol 1996;87:59-64.
29. Daling JR, Sherman KJ. Relationship between human papillomavirus infection and tumors of anogenital sites other than the cervix IARC sci Publ 1992;119:223-41.
30. Brinton LA, Nasca PC, Mallin K, Schairer C, Rosenthal J, Rothenberg R, et al. Case-control study of in situ and invasive carcinoma of the vagina. Gynecol Oncol 1990;38:49-54.
31. Messing MJ, Gallup DG. Carcinoma of the vulva in young women. Obstet Gynecol 1995;86:51-4.
32. Frisch M, Melbye M, Moller H. Trends in incidence of anal cancer in Denmark. BMJ 1993;306:419-22.
33. Goldman S, Glimelius B, Nilsson B, På L. Incidence of anal epidermoid carcinoma in Sweden 1970-1984. Arta Chir Scand 1989;155:191-7.
34. Li J, Li FP, Blot WJ, Miller RW, Fraumeni JF Jr. Correlation between cancers of the uterine cervix and penis in China. J Natl Cancer Inst. 1982;69:4063-5.
35. Graham S, Priore R, Graham M, Browne R, Burnett West, D. Genital cancer in wives of penile cancer patients. Cancer 1979;44:1870-4.
36. Aynaud O, Ionesco M, Barrasso R. Penile intraepithelial neoplasia. Specific clinical features correlate with histologic and virologic findings. Cancer 1994;74:1762-7.